• SCH772984 HCl: Advanced Workflows for ERK1/2 Inhibition

  2026-06-25

  SCH772984 HCl stands out as a highly potent ERK1/2 inhibitor, enabling researchers to dissect MAPK pathway resistance and telomerase regulation in BRAF- and RAS-mutant tumor models. Discover protocol enhancements, troubleshooting insights, and practical bridges to emerging DNA repair research.

• 20-HETE–TRPV1–MrgprA3+ Axis Drives Itch in Chronic Dermatiti

  2026-06-25

  This study uncovers how elevated 20-HETE in chronic dermatitis sensitizes TRPV1 channels on MrgprA3+ neurons, causing capsaicin to evoke both pain and itch. These findings clarify the neural mechanisms of sensory switching in chronic itch and highlight new therapeutic targets for pruritus management.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-06-24

  Oliveira et al. reveal that naturally occurring angiotensin peptides—including Angiotensin III—can enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, implicating a molecular connection between the renin-angiotensin system and viral pathogenesis. These findings highlight potential research directions for both cardiovascular and infectious disease fields.

• LC–MS/MS Elucidates GS-441524 Prodrug Pathways and Pharmacok

  2026-06-23

  This study introduces a novel GS-441524 prodrug (NGP-1) and employs a newly established LC–MS/MS method to reveal its conversion to the active antiviral metabolite in vitro and in vivo. The findings provide foundational insights for optimizing anti-SARS-CoV-2 nucleoside analog development and inform experimental strategies for pharmacokinetic and metabolic research.

• hCG Regulates CXCL10 via Histone Methylation in Human Decidu

  2026-06-23

  This study uncovers how human chorionic gonadotropin (hCG) suppresses CXCL10 expression in human decidual stromal cells through EZH2-mediated H3K27me3 histone methylation. These findings reveal a key epigenetic mechanism modulating maternal immune cell recruitment at the maternal-fetal interface, with implications for immune tolerance and pregnancy success.

• Reserpine (N1867): Technical Guidance for Neuropharmacology

  2026-06-22

  Reserpine is a high-purity, research-use-only compound that supports reproducible workflows in neurotransmitter depletion research and antihypertensive mechanism studies. It should only be used in controlled laboratory settings and is not suitable for diagnostic, clinical, or veterinary applications due to its potent biological activity and strict handling requirements.

• ApexPrep DNA Plasmid Miniprep Kit: Optimizing Molecular Biol

  2026-06-22

  Unlock reproducible, high-purity plasmid DNA extraction for demanding molecular biology workflows with the ApexPrep DNA Plasmid Miniprep Kit. Discover evidence-driven optimizations and troubleshooting strategies that bridge advanced applications—from gene cloning to AML research—with streamlined, robust purification.

• Streptavidin-FITC: Precision Fluorescence for Biotin Detecti

  2026-06-21

  Streptavidin-FITC empowers sensitive, reproducible detection of biotinylated molecules across advanced imaging and flow cytometry workflows. APExBIO’s conjugate delivers robust performance for intracellular trafficking studies, immunohistochemistry, and nucleic acid tracking, with data-driven guidance for protocol optimization and troubleshooting.

• PP2A-Mediated Autophagy Drives Drug Resistance in C. albican

  2026-06-20

  This study establishes that protein phosphatase 2A (PP2A) regulates autophagy-dependent biofilm formation and antifungal drug resistance in Candida albicans. By delineating the molecular link between PP2A-induced ATG protein phosphorylation and biofilm resilience, the paper suggests new avenues for targeting persistent fungal infections.

• Partial BACE1 Inhibition Reduces Amyloid Beta Without Synapt

  2026-06-19

  Satir et al. (2020) demonstrate that moderate inhibition of BACE1, the β-secretase involved in amyloid precursor protein processing, can reduce amyloid beta production by up to 50% without impairing synaptic transmission in neuronal cultures. These findings provide a critical framework for optimizing BACE inhibitor dosing in Alzheimer's disease research and support precision approaches for minimizing off-target neurological effects.

• Cyclic di-GMP: Advanced Workflows for Biofilm and Immunity R

  2026-06-19

  Cyclic di-GMP stands at the crossroads of bacterial genome stability and innate immune modulation, uniquely enabling dual-domain experimental designs. This article details robust protocols, troubleshooting strategies, and innovative applications for maximizing reproducibility and insight in infection biology and cancer immunotherapy studies.

• SkQ1 and Mitochondrial Apoptosis in Muscle Atrophy During Ov

  2026-06-18

  This study evaluates whether mitochondrial-targeted antioxidant SkQ1 can prevent skeletal muscle atrophy by inhibiting apoptotic and necroptotic signaling in a mouse model of ovarian cancer. The findings reveal that while SkQ1 suppresses mitochondrial apoptosis signaling, it does not prevent muscle atrophy, challenging the assumed causality between mitochondrial cell death pathways and cancer cachexia.

• High-Sensitivity Yeast Platform Accelerates mTOR Inhibitor D

  2026-06-18

  This study introduces a drug-sensitized yeast system that enables rapid, cost-effective, and highly sensitive detection of mTOR (TOR) inhibitors. The approach represents a major methodological advance for identifying compounds with geroprotective or anti-cancer potential, and provides robust negative controls for compounds like Nebivolol hydrochloride that do not affect the TOR pathway.

• Mechanistic Insights into Gyrase Inhibition: Lessons from Ge

  2026-06-17

  This article analyzes the mechanistic and structural basis of gepotidacin’s action against Staphylococcus aureus gyrase, revealing a novel inhibition mode distinct from classic fluoroquinolones. The findings provide new perspectives on antibiotic design, resistance, and research applications relevant to DNA gyrase-targeting compounds.

• Strainer Platform Advances Immunolabeling of PEDV-Infected O

  2026-06-17

  This study introduces a strainer-based method for the efficient collection and immunolabeling of porcine intestinal organoids infected by porcine epidemic diarrhea virus (PEDV). The innovation streamlines workflows for virus-host interaction studies, offering a reproducible, species-adaptable platform with implications for organoid-based disease models.

14377 records 1/959 page Next 12345 下5页 Last page